INIS
tumors
100%
biological markers
66%
death
66%
ligands
66%
immunotherapy
50%
cancer
33%
patients
33%
lung cells
33%
levels
16%
tissues
16%
correlations
16%
testing
16%
therapy
16%
diseases
16%
genes
16%
reviews
16%
mutations
16%
inhibition
16%
validation
16%
utilities
16%
density
16%
lymphocytes
16%
genotype
16%
Medicine and Dentistry
Neoplasm
66%
Biological Marker
66%
Programmed Death 1 Ligand 1
66%
Immunotherapy
50%
Marker
50%
Lung Cancer
33%
Serum
33%
Patient
33%
Cells
33%
Diseases
16%
Combination Therapy
16%
Treatment Response
16%
Genotype
16%
Tumor Microenvironment
16%
Tumor Infiltrating Lymphocyte
16%
Immunotoxicity
16%
Tissues
16%
Aptitude
16%
Experience
16%
Survival
16%
Immunology and Microbiology
Programmed Death 1 Ligand 1
66%
Immunotherapy
50%
Immunohistochemistry
33%
Cells
33%
Lung
33%
Mutation
16%
Genotype
16%
Electric Potential
16%
Tumor-Infiltrating Lymphocytes
16%
Survival
16%
Tissues
16%
Immunity
16%
Experience
16%
Aptitude
16%
Density
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
66%
Biological Marker
66%
Programmed Death 1 Ligand 1
66%
Immunotherapy
50%
Lung Cancer
33%
Diseases
16%
Tumor Microenvironment
16%
Survival
16%
Immunotoxicity
16%
Chemistry
Biological Marker
66%
Programmed Death-Ligand 1
66%
Marker
50%
% Inhibition
16%
Mutation
16%
Oncogenic
16%
Concentration
16%
Density
16%
Potential
16%
Correlation
16%
Biochemistry, Genetics and Molecular Biology
Gene Expression Profiling
33%
Mutation
16%
Electric Potential
16%
Genotyping
16%
Experience
16%
Aptitude
16%
Survival
16%
Density
16%